Icecure Medical (Icecure Medical) Change In Receivables : $-0.03 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Icecure Medical Change In Receivables?

Icecure Medical's change in receivables for the quarter that ended in Dec. 2023 was $0.01 Mil. It means Icecure Medical's Accounts Receivable declined by $0.01 Mil from Sep. 2023 to Dec. 2023 .

Icecure Medical's change in receivables for the fiscal year that ended in Dec. 2023 was $-0.03 Mil. It means Icecure Medical's Accounts Receivable increased by $0.03 Mil from Dec. 2022 to Dec. 2023 .

Icecure Medical's Accounts Receivable for the quarter that ended in Dec. 2023 was $0.10 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Icecure Medical's Days Sales Outstanding for the three months ended in Dec. 2023 was 7.49.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Icecure Medical's liquidation value for the three months ended in Dec. 2023 was $8.03 Mil.

Icecure Medical Change In Receivables Historical Data

The historical data trend for Icecure Medical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icecure Medical Change In Receivables Chart

Icecure Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

0.10

-0.08

-0.36

0.38

-0.03

Icecure Medical Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															0.12	-0.07	0.03	0.01	0.01

Icecure Medical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

Icecure Medical (NAS:ICCM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Icecure Medical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.103	/	1.255	*	91
=	7.49

2. In Ben Graham's calculation of liquidation value, Icecure Medical's accounts receivable are only considered to be worth 75% of book value:

Icecure Medical's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	11.062	-	4.247	+	0.75 * 0.103	+	0.5 * 2.275
=	8.03

Icecure Medical Change In Receivables Related Terms

Thank you for viewing the detailed overview of Icecure Medical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Icecure Medical (Icecure Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Icecure Medical Ltd (NAS:ICCM) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Haeshel Street, Southern Industrial Park, PO Box 3163, Caesarea, ISR, 3079504

Website

https://www.icecure-medical.com

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.